CrowdWisers™--- the subscriber area has no ads and those above are not selected or endorsed by this site ---
eMagin 2Q16 results ?4
11:44 11-Aug-16
eMagin reported
results last night, with a loss of 7 cents per share missing by 3
cents on sales of $5.53M, which misses by $1.47M. I don't see
either of these as very important.
A new subscriber asks:
I had actually meant to mention eMagin in last night's update, in the VR section. My apologies for not doing so. The press release characterized the manufacturing issue as having been resolved, but Q&A discussed delivery of a new machine still being pending with rapid ramp up to follow that. My take is that real mass production for VR headsets is still at least a year off. Much of the recent rise was due to acknowledgment from Advanced Micro Devices, but that conversation no longer seems to be current.One of the stock you mentioned EMAN just had an earning release and the price is down 20%. It looked like they still could not resolve the manufacturing problem you mentioned earlier. Another concern I have is to support multiple costumers and develop new products, they are burning a lot of cash. With only 6m cash, they may need to raise cash. What is your take?
The $825K medical device industry sale is a positive, though, and projections of 2 product launches in the fourth quarter are encouraging. Cash burn has been inconsistent, and the danger of a capital raise could be avoided depending on the costs of the product launch, which were not quantified. Although a 20%+ drop in the stock price may have been overdone, in the current market, I prefer to wait and see how things progress and what the terms of new capital are, should that need to happen.